We share our expertise in a steadily growing market for fluorochemicals in the pharmaceuticals industry. As fluororganic materials are increasingly used in the materials sciences, our core business remains the development of novel fluorinated materials that are difficult to make using standard fluorination protocols. Our expertise in deoxofluorination processes and direct fluorination technology provides the basis to access a wide range of aliphatic-, alicyclic-, and heterocyclic fluororganic compounds in the most cost efficient manner.

Selected Publications: